1. Scrip

Eight COVID-19 Vaccines Approved In India In 2021, mRNA Addition Awaited

 
• By Vibha Ravi

While an mRNA vaccine is still missing, 2021 saw Indian companies strike alliances, battle legal action and gain funding while the regulator played a crucial enabling role in the run up to the approval of eight COVID-19 vaccines from zero in 2020.

Vaccines
The 2021 Spotlight Was On COVID-19 Vaccines • Source: Alamy

Just as 2021 was drawing to a close, the Drugs Controller General of India gave approval for restricted use in emergency situation to COVID-19 vaccines from Novavax, Inc. partner Serum Institute of India Pvt. Ltd. and Baylor College of Medicine partner Biological E. Ltd.

India got its first two coronavirus vaccines in January 2021 and with four others approved during the course of last year, the tally stood at eight

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from COVID-19

More from Scrip

Novo Nordisk’s CEO Forced Out After Falling Behind In GLP-1 Battle

 
• By Andrew McConaghie

Company surprises investors with Jørgensen's exit but insists its strategy will not change.

In Brief: US FDA Delay Sends Biohaven Shares Down

 
• By Andrew McConaghie

The US regulator’s decision has taken Biohaven and investors by surprise, with the reason for a ‘major amendment’ status not clear.

Executives On The Move: Pathos Procures CEO From AstraZeneca, New CEO For TME Pharma, And More

Recent moves in the industry include changes at the top at Akamis Bio, Innospera Pharma & Ispen, plus Astellas Korea appoints an ex-Novartis Korea executive.